Neuroscience Research
Neuroscience is the study of the nervous system - one of the major mammalian systems responsible for sustaining life. The central nervous system (CNS) and peripheral nervous system (PNS) work in concert to coordinate basic functions such as moving and breathing, as well as 'higher order' functions including thought, speech and emotion.
Neuroscience Research Products Areas
- Stress and Anxiety Research (392)
- Nociception (957)
- Neurotransmission (892)
- Neuropeptides (43)
- Neural Development (795)
- Memory, Learning and Cognition (746)
- Blood-Brain Barrier (119)
- Stroke Research (665)
- Sleep Research (267)
- Schizophrenia Research (709)
- Parkinson's Disease Research (752)
- Huntington's Disease Research (465)
- Epilepsy Research (560)
- Depression Research (631)
- Alzheimer's Disease Research (399)
- Addiction Research (509)
- Multiple Sclerosis (419)
Products for Neuroscience Research - Page 41
- Cat.No. Product Name Information/Activity
-
BCC1264
Cabozantinib (XL184, BMS-907351)
Cabozantinib is a potent multiple receptor tyrosine kinases (RTKs) inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
-
BCC5098
ZM 323881 HCl
ZM323881 hydrochloride is a potent and selective VEGFR2 inhibitor with an IC50 of less than 2 nM.
-
BCC4316
CGS 21680 HCl
CGS 21680 Hydrochloride is a selective adenosine A2A receptor agonist with a Ki of 27 nM.
-
BCC7163
CV 1808
53296-10-9
-
BCC6237
LUF 5834
333962-91-7
-
BCC7815
ANR 94
Adenosine A<sub>2A </sub>antagonist
-
BCC3798
Istradefylline (KW-6002)
Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson's disease.
-
BCC7977
Lu AA 47070
913842-25-8
-
BCC7372
SCH 442416
316173-57-6
-
BCC7306
SCH 58261
SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.


